lobbying_activities: 1345229

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1345229	511eadad-5ed3-4357-92b9-34d7dce0ec06	Q4	TARPLIN, DOWNS & YOUNG, LLC	304736	BIOTECHNOLOGY INDUSTRY ORGANIZATION	2012	fourth_quarter	PHA	see addendum page Prescription drug importation S. 319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147 - Prescription Drug Affordability Act S. 296 - Drug Shortage Act PL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation *, no specific bill(s), Drug Safety, Prescription Drug Importation, Import Safety, supply chain integrity, biosimilars, PDUFA and associated policies, patent settlements, accelerated approval, break through therapies	Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE	80000		0	0	2013-01-18T15:27:05.300000-05:00